Biofrontera (BFRI) Shares Outstanding (2020 - 2025)

Biofrontera's (BFRI) quarterly Shares Outstanding (Entity) came in at $11.6 million in Q4 2025, up 111.16% year-on-year from $5.5 million in Q4 2024, and little changed quarter-over-quarter from $11.6 million in Q3 2025.

Biofrontera (BFRI) Shares Outstanding (2020 - 2025) Analysis & Trends

Biofrontera's Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $11.6 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Entity) rose 111.16% year-over-year to $11.6 million in Q4 2025; TTM through Dec 2025 was $11.6 million, a 111.16% increase from a year earlier, with the FY2025 full-year figure at $11.6 million, up 111.16% from the prior year.
  • Shares Outstanding (Entity) was little changed at $11.6 million in Q4 2025 per BFRI's latest filing, from $11.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $440.4 million in Q4 2021 and bottomed at $400000.0 in Q1 2021.
  • The 5-year median for Shares Outstanding (Entity) is $1.4 million (2023), against an average of $25.7 million.
  • Across the five-year window, Shares Outstanding (Entity) surged 38338.72% in 2021 and sank 99.76% in 2022, its largest moves.
  • Year by year, Shares Outstanding (Entity) stood at $440.4 million in 2021, then sank by 99.76% to $1.1 million in 2022, then jumped by 43.58% to $1.5 million in 2023, then soared by 263.48% to $5.5 million in 2024, then jumped by 111.16% to $11.6 million in 2025.
  • Per Business Quant, the three latest BFRI Shares Outstanding (Entity) figures stand at $11.6 million (Q4 2025), $11.6 million (Q3 2025), and $10.1 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 8.98 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.16 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 422.10 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 43.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 455,871.00
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 100.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 497.70 Mn
10 Biofrontera 12.70 Mn 6.29 Mn 14.09 Mn 10.17 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 10.17 Mn
Sep 30, 2025 10.78 Mn
Jun 30, 2025 9.35 Mn
Mar 31, 2025 8.87 Mn
Dec 31, 2024 5.52 Mn
Sep 30, 2024 5.77 Mn
Jun 30, 2024 5.09 Mn
Mar 31, 2024 3.62 Mn
Dec 31, 2023 1.55 Mn
Sep 30, 2023 1.37 Mn
Jun 30, 2023 1.36 Mn
Mar 31, 2023 1.33 Mn
Dec 31, 2022 1.06 Mn
Sep 30, 2022 1.14 Mn
Jun 30, 2022 941,175.00
Mar 31, 2022 855,237.00
Dec 31, 2021 440.41 Mn
Sep 30, 2021 400,000.00
Jun 30, 2021 400,000.00
Mar 31, 2021 400,000.00